MBAPL Q2 FY27 Revenue Surges 59% to ₹715 Cr; PAT Jumps 155% to ₹78 Cr
Madhya Bharat Agro Products Limited (MBAPL) reported a strong Q2 FY27 with revenue up 59% YoY to ₹715 crore and PAT soaring 155% to ₹78 crore. H1 FY27 revenue increased 32% to ₹1,135 crore, with PAT up 89% to ₹119 crore. The company commissioned new facilities and benefits from increased government subsidies.
The substantial financial growth, coupled with strategic capacity expansions and favorable government policies, indicates a significant positive impact on the company's performance and future prospects.
The company reported significant year-on-year growth in revenue, EBITDA, and PAT for both the quarter and half-year periods. The commissioning of new facilities and positive government policy support further contribute to the positive sentiment.
Madhya Bharat Agro Products Limited (MBAPL) announced its financial results for the quarter and half-year ended September 30, 2026 (Q2 & H1 FY27). The company reported a robust performance, with Q2 FY27 revenue growing by 59% year-on-year to ₹715 crore. EBITDA increased by 107% to ₹128 crore, and Profit After Tax (PAT) surged by 155% to ₹78 crore.
For the first half of FY27 (H1 FY27), revenue stood at ₹1,135 crore, marking a 32% increase year-on-year. EBITDA for H1 FY27 grew by 66% to ₹197 crore, and PAT saw a significant rise of 89% to ₹119 crore.
The company highlighted the commissioning of its new NPK/DAP and backward-integrated phosphoric acid facilities at Dhule as a key milestone. MBAPL also noted the positive impact of the Government of India's increased Nutrient-Based Subsidy (NBS) rates for the Rabi 2026-27 season, which provides a strong policy tailwind for domestic phosphatic and complex fertilizer production.
MBAPL is strategically expanding its fertilizer capacity from approximately 0.9 million MT to 1.6 million MT, with planned expansions in SSP, NPK/DAP, and backward integration capacities. The company aims to strengthen production, improve capacity utilization, enhance operational efficiency, and expand its presence in the NPK segment.
What to do with a filing like this
Madhya Bharat Agro Products Limited filed this with the NSE as a statutory disclosure, categorised under quarterly results. It is a primary document, not a recommendation, and the desk marks it high impact, which is the band that most often changes something.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Madhya Bharat Agro Products Limited. Read the original for the full detail.